Shape-Sensing Robotic Bronchoscopy With Simultaneous Biopsy of Multiple Ipsilateral and Bilateral Pulmonary Nodules

🩺 Clinical Context

The management of multiple pulmonary nodules (MPNs) presents a significant diagnostic challenge in interventional pulmonology. Traditional navigational bronchoscopy often requires multiple procedures or compromises in diagnostic yield when targeting bilateral or widely dispersed lesions. This study evaluates the utility of shape-sensing robotic-assisted bronchoscopy (RAB) to perform simultaneous biopsies of multiple ipsilateral and bilateral nodules in a single session. This is a critical step toward increasing the efficiency of the diagnostic pathway, reducing the need for repeat procedures, and potentially accelerating the time to treatment for patients with multifocal disease.

📊 Methodological Strengths & Weaknesses

Strengths:

• Clinical Utility: The study addresses a “real-world” clinical scenario—the patient with multiple suspicious nodules—which is frequently excluded from or underrepresented in pivotal trials of navigational platforms.
• Technical Feasibility: It demonstrates the reach and stability of shape-sensing robotic platforms in navigating complex, multi-quadrant anatomy, which is often the primary limitation of traditional electromagnetic navigation (ENB).
• Efficiency: By documenting the ability to biopsy multiple sites in one session, the study provides a strong argument for the cost-effectiveness and patient-centered benefits of robotic platforms.

Weaknesses:

• Selection Bias: As a retrospective or observational analysis (typical for early-stage robotic data), the study likely reflects “best-case” scenarios or high-volume centers, limiting generalizability to lower-volume practices.
• Diagnostic Yield vs. Technical Success: The study focuses heavily on the ability to reach and biopsy multiple sites. It is crucial to distinguish between technical success (reaching the target) and diagnostic yield (obtaining a definitive pathological diagnosis), as the latter is influenced by lesion size, location, and the quality of the rapid on-site evaluation (ROSE).
• Lack of Long-term Follow-up: The study does not fully address the clinical outcomes of patients with negative biopsies, which is essential for calculating the true negative predictive value (NPV) in a multifocal cohort.

💡 Takeaway for Fellows

• The “One-Stop Shop” Paradigm: We are moving toward a future where “one-and-done” diagnostic bronchoscopy is the standard, even for complex, multifocal disease. If you have a patient with bilateral nodules, don’t reflexively stage them for two separate procedures; evaluate the feasibility of a single robotic session.
• Anatomical Planning is Paramount: The success of multi-nodule biopsy relies entirely on your pre-procedural planning. Use the robotic software to map the most efficient “path of least resistance” to avoid airway trauma or excessive scope manipulation that could lead to edema and hinder subsequent biopsies.
• Manage Expectations: While the technology is impressive, the diagnostic yield for small, peripheral nodules remains dependent on the quality of the biopsy technique (e.g., transbronchial needle aspiration vs. forceps) and the presence of a dedicated cytopathologist. Always prioritize the highest-risk nodule if time or patient tolerance becomes a limiting factor during the procedure.